Medical Excellence Capital, LLC

About

Medical Excellence Capital | Precision Capital Advancing Precision Health(R) Approach Team Council Portfolio Foundation News Blog PRECISION CAPITAL ADVANCING PRECISION HEALTH ® Our Approach A PURPOSE-BUILT VENTURE FIRM We combined accomplished investment professionals and operators with a proprietary national medical network platform to create the most unique venture firm in life sciences. MEC deploys precision capital to nurture and advance the precision health innovations that solve the biggest, most complex medical problems. Proprietary Network of the World’s Leading Physician Scientists > Team of Experienced VCs, Company Creators and Operators > MEDICAL EXCELLENCE CAPITAL A Differentiated Early-Stage Life Sciences Venture Fund > ADVANCING THE PRECISION HEALTH DECADE At MEC, we believe the technologies created in this decade will utilize artificial intelligence and lead to a golden age in innovation within the life sciences space. MEC invests in company creation, seed, Series A, and Series B opportunities where technology and novel approaches are transformative for patient care and directly address large, unmet needs. Our areas of focus include: OUR PORTFOLIO Aspen Neuroscience Active Immunitas Therapeutics Active Nobias Therapeutics Active ProJenX Active View All NEWS BLOG View the latest posts and investment news from MEC. Press Release GC Therapeutics Appoints Stem Cell Therapy Leader Stefan Irion, MD, as Chief Scientific Officer Read More Blog Post MEC in Q1 2026: Intr

Key Contact

Geographic Focus